ProductsDistribution Products

Trimbow 200/6/12.5

Therapeutic indication:

TRIMBOW 200/6/12.5 is indicated for maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.

  • Composition: Glycopyrronium bromide 12.5 mcg, Formoterol fumarate dihydrate 6 mcg, Beclometasone dipropionate 200 mcg
  • Pharmaceutical form: PRESSURISED INHALATION, SOLUTION
  • Method of administration: INHALATION
  • Manufacturer: CHIESI FARMACEUTICI S.P.A, ITALY